BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27881354)

  • 41. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
    Opastirakul S; Chartapisak W
    Pediatr Nephrol; 2005 Dec; 20(12):1750-5. PubMed ID: 16133037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Herpes-zoster virus infection in patients with systemic lupus erythematosus].
    Moga I; Formiga F; Canet R; Pac M; Mitjavila F; Pujol R
    Rev Clin Esp; 1995 Aug; 195(8):530-3. PubMed ID: 7569198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?
    Riccieri V; Spadaro A; Parisi G; Taccari E; Moretti T; Bernardini G; Favaroni M; Strom R
    Lupus; 2000; 9(5):333-7. PubMed ID: 10878724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients.
    Wu Z; Zhang S; Zhao L; Fei Y; Wang L; Li J; Wen X; Zeng X; Zhang F; Li Y
    Clin Rheumatol; 2017 Oct; 36(10):2281-2287. PubMed ID: 28821990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
    Cabrera CM; Urra JM; Carreño A; Zamorano J
    Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine profile of herpes zoster (HZ/su) subunit vaccine.
    Cunningham AL; Heineman T
    Expert Rev Vaccines; 2017 Jul; 16(7):1-10. PubMed ID: 28486850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent inflammation-immunosuppression-catabolism syndrome in patients with systemic lupus erythematosus.
    Li Z; Hu W; Wang Y; Xu S; Zhou Y; Li S
    Int Urol Nephrol; 2023 Jul; 55(7):1757-1765. PubMed ID: 36739569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural Killer Cell Count in Systemic Lupus Erythematosus Patients: A Flow Cytometry-Based Study.
    Thangjam N; Dey B; Khonglah Y; Tiewsoh I; Ksoo R
    Cureus; 2023 Oct; 15(10):e46885. PubMed ID: 37954751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Herpes zoster in patients with systemic lupus erythematosus: Clinical features, complications and risk factors.
    Chen D; Li H; Xie J; Zhan Z; Liang L; Yang X
    Exp Ther Med; 2017 Dec; 14(6):6222-6228. PubMed ID: 29285180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.
    Comte D; Karampetsou MP; Yoshida N; Kis-Toth K; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2017 May; 69(5):1035-1044. PubMed ID: 28076903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics.
    Pool AJ; Whipp BJ; Skasick AJ; Alavi A; Bland JM; Axford JS
    Rheumatology (Oxford); 2004 Jan; 43(1):43-8. PubMed ID: 12867581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe Herpes Zoster Secondary to Systemic Lupus Erythematosus Successfully Treated with Ultraviolet A1 Phototherapy: A Case Report.
    Kong M; Li J; Wang H; Song Z; Chen Q
    Photobiomodul Photomed Laser Surg; 2023 Jan; 41(1):26-29. PubMed ID: 36629900
    [No Abstract]   [Full Text] [Related]  

  • 56. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between peripheral blood lymphocyte subpopulations and primary systemic lupus erythematosus.
    Feng Y; Li Z; Xie C; Lu F
    Open Life Sci; 2022; 17(1):839-845. PubMed ID: 36045722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus.
    Miao J; Qiu F; Li T; Zhao P; Zhang K; Lv M; Wan J; Qi X; Zhu P
    Mediators Inflamm; 2016; 2016():2842143. PubMed ID: 27065298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Herpes zoster myelitis occurring during treatment for systemic lupus erythematosus.
    Ebo DG; DeClerck LS; Stevens WJ; Ieven M; Ursi D; Van Goethem JW; Couttenye MM
    J Rheumatol; 1996 Mar; 23(3):548-50. PubMed ID: 8833001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-lymphocyte subsets in otherwise healthy patients with herpes zoster and relationships to the duration of acute herpetic pain.
    Higa K; Noda B; Manabe H; Sato S; Dan K
    Pain; 1992 Oct; 51(1):111-118. PubMed ID: 1454393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.